Answers are grounded in this paper and cite their sources.
This study evaluated the hypolipidemic effect of vine tea flavonoids (AGF) in high-fat diet-fed rats. Animals received low-, medium-, or high-dose AGF (50, 100, or 200 mg/kg BW) for seven weeks, with Xuezhikang (60 mg/kg BW) as a positive control. The results showed that AGF, particularly the high dose (H-AGF), significantly reduced body weight, liver weight, hepatic lipid accumulation, and markers of liver damage (ALT, AST). H-AGF also improved serum lipid profiles by lowering TC, TG, and LDL-C while increasing HDL-C, enhanced antioxidant capacity, and promoted beneficial gut bacteria such as Lactobacillus and Collinsella. Transcriptome analysis further revealed that H-AGF modulated key genes involved in triglyceride, cholesterol, and fatty acid metabolism pathways. Overall, the H-AGF was more effective than Xuezhikang in most measured outcomes. Thus, AGF can be developed in the future as a potential natural resource for hypolipidemic drugs, functional foods, and additives.
No takes yet. Share an insight, caveat, or question.
Shi et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: